NPCE Live signaler | Maksimer profitt med Getagraph.com

KJøP 119065 min ago

@ $16.08

Utstedt: 12 feb 2024 @ 15:30

Avkastning: -15.17%

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	42 933.00
Gjennomsnittsvolum	108 398
Markedsverdi	391.74M
EPS	$0 ( 2024-05-02 )
Neste inntjeningsdato	( $-0.320 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.74
ATR14	$0.0360 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Orbimed Advisors Llc	Sell	15 690	Common Stock
2024-05-02	Orbimed Advisors Llc	Sell	8 842	Common Stock
2024-05-03	Orbimed Advisors Llc	Sell	4 674	Common Stock
2024-04-24	Orbimed Advisors Llc	Sell	1 781	Common Stock
2024-04-19	Orbimed Advisors Llc	Sell	18 253	Common Stock

INSIDER POWER
15.32
Last 97 transactions
Buy: 3 318 075 \| Sell: 1 148 594

Volum Korrelasjon

Lang: 0.05 (neutral)

Kort: 0.63 (weak)

Signal:(39.699) Neutral

NeuroPace, Inc. Korrelasjon

10 Mest positive korrelasjoner
ICCM	0.892
RBKB	0.891
PROV	0.891
ISTR	0.889
FCRD	0.889
CPLP	0.889
NSTS	0.88
ALTR	0.875
WTFCM	0.87
WLTW	0.859

10 Mest negative korrelasjoner
MLVF	-0.88
PFBI	-0.868
ADN	-0.862
RMRM	-0.861
XPDI	-0.856
BJDX	-0.85
CNSP	-0.847
BFRI	-0.844
KC	-0.843
RIBT	-0.837

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

NeuroPace, Inc. Korrelasjon - Valuta/Råvare

0.07
( neutral )

0.61
( weak )

0.00
( neutral )

-0.55
( weak negative )

-0.54
( weak negative )

NeuroPace, Inc. Økonomi

Annual	2023
Omsetning:	$65.42M
Bruttogevinst:	$48.12M (73.56 %)
EPS:	$-1.270

FY	2023
Omsetning:	$65.42M
Bruttogevinst:	$48.12M (73.56 %)
EPS:	$-1.270

FY	2022
Omsetning:	$45.52M
Bruttogevinst:	$32.49M (71.38 %)
EPS:	$-2.17

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.497

Financial Reports:

No articles found.

NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Sanntidsoppdatering for NeuroPace, Inc. [NPCE]

Upcoming Earnings Alert